Cargando…

Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis

BACKGROUND: Skin-restricted lupus is a chronic inflammatory disease associated with high rates of depression and anxiety disorders. Patients without psychiatric disorders can experience anxiety and depressive symptoms at a subclinical level, which could be risk factors for progression towards psychi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rondepierre, Fabien, Tauveron-Jalenques, Urbain, Valette, Solène, Mulliez, Aurélien, D’Incan, Michel, Lauron, Sophie, Jalenques, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977055/
https://www.ncbi.nlm.nih.gov/pubmed/36857334
http://dx.doi.org/10.1371/journal.pone.0282079
_version_ 1784899212358451200
author Rondepierre, Fabien
Tauveron-Jalenques, Urbain
Valette, Solène
Mulliez, Aurélien
D’Incan, Michel
Lauron, Sophie
Jalenques, Isabelle
author_facet Rondepierre, Fabien
Tauveron-Jalenques, Urbain
Valette, Solène
Mulliez, Aurélien
D’Incan, Michel
Lauron, Sophie
Jalenques, Isabelle
author_sort Rondepierre, Fabien
collection PubMed
description BACKGROUND: Skin-restricted lupus is a chronic inflammatory disease associated with high rates of depression and anxiety disorders. Patients without psychiatric disorders can experience anxiety and depressive symptoms at a subclinical level, which could be risk factors for progression towards psychiatric disorders. It was decided, therefore, to investigate the presence of specific symptoms in skin-restricted lupus patients without axis I psychiatric disorders and their impact on the occurrence of axis I psychiatric disorders during the study follow-up. METHODS: Longitudinal data of 38 patients and 76 matched controls without active axis I psychiatric disorders from the LuPsy cohort were used. Depressive, neurovegetative, psychic and somatic anxiety symptom scores were established from the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Anxiety Rating scale (HAMA). RESULTS: None of the participants had any current active axis I psychiatric disorders but the patients had personality disorders more frequently and had received more past psychotropic treatments than the controls. They also had higher MADRS and HAMA scores than the controls, in particular neurovegetative, psychic anxiety and somatic symptoms scores. No dermatological factor tested was associated with these scores, whereas being a lupus patient was associated with higher neurovegetative and somatic symptoms scores, having a current personality disorder with higher depressive and neurovegetative scores and receiving more past psychotropic treatments with psychic anxiety and somatic symptoms scores. The occurrence of psychiatric disorders during the study follow-up was associated with an elevated psychic anxiety score at baseline and past psychotropic treatment but not with history of psychiatric disorder. LIMITATIONS: The LuPsy cohort included a large number of patients with axis I psychiatric disorders, the sample without axis I psychiatric disorders is therefore limited. CONCLUSIONS: We observed numerous psychiatric symptoms among the skin-restricted lupus patients. They should therefore receive special attention in the management of their subclinical symptoms before they progress towards full psychiatric disorders.
format Online
Article
Text
id pubmed-9977055
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-99770552023-03-02 Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis Rondepierre, Fabien Tauveron-Jalenques, Urbain Valette, Solène Mulliez, Aurélien D’Incan, Michel Lauron, Sophie Jalenques, Isabelle PLoS One Research Article BACKGROUND: Skin-restricted lupus is a chronic inflammatory disease associated with high rates of depression and anxiety disorders. Patients without psychiatric disorders can experience anxiety and depressive symptoms at a subclinical level, which could be risk factors for progression towards psychiatric disorders. It was decided, therefore, to investigate the presence of specific symptoms in skin-restricted lupus patients without axis I psychiatric disorders and their impact on the occurrence of axis I psychiatric disorders during the study follow-up. METHODS: Longitudinal data of 38 patients and 76 matched controls without active axis I psychiatric disorders from the LuPsy cohort were used. Depressive, neurovegetative, psychic and somatic anxiety symptom scores were established from the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Anxiety Rating scale (HAMA). RESULTS: None of the participants had any current active axis I psychiatric disorders but the patients had personality disorders more frequently and had received more past psychotropic treatments than the controls. They also had higher MADRS and HAMA scores than the controls, in particular neurovegetative, psychic anxiety and somatic symptoms scores. No dermatological factor tested was associated with these scores, whereas being a lupus patient was associated with higher neurovegetative and somatic symptoms scores, having a current personality disorder with higher depressive and neurovegetative scores and receiving more past psychotropic treatments with psychic anxiety and somatic symptoms scores. The occurrence of psychiatric disorders during the study follow-up was associated with an elevated psychic anxiety score at baseline and past psychotropic treatment but not with history of psychiatric disorder. LIMITATIONS: The LuPsy cohort included a large number of patients with axis I psychiatric disorders, the sample without axis I psychiatric disorders is therefore limited. CONCLUSIONS: We observed numerous psychiatric symptoms among the skin-restricted lupus patients. They should therefore receive special attention in the management of their subclinical symptoms before they progress towards full psychiatric disorders. Public Library of Science 2023-03-01 /pmc/articles/PMC9977055/ /pubmed/36857334 http://dx.doi.org/10.1371/journal.pone.0282079 Text en © 2023 Rondepierre et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Rondepierre, Fabien
Tauveron-Jalenques, Urbain
Valette, Solène
Mulliez, Aurélien
D’Incan, Michel
Lauron, Sophie
Jalenques, Isabelle
Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis
title Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis
title_full Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis
title_fullStr Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis
title_full_unstemmed Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis
title_short Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis
title_sort psychiatric symptomatology in skin-restricted lupus patients without axis i psychiatric disorders: a post-hoc analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977055/
https://www.ncbi.nlm.nih.gov/pubmed/36857334
http://dx.doi.org/10.1371/journal.pone.0282079
work_keys_str_mv AT rondepierrefabien psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis
AT tauveronjalenquesurbain psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis
AT valettesolene psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis
AT mulliezaurelien psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis
AT dincanmichel psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis
AT lauronsophie psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis
AT jalenquesisabelle psychiatricsymptomatologyinskinrestrictedlupuspatientswithoutaxisipsychiatricdisordersaposthocanalysis